EP4704833A2 - Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen - Google Patents

Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen

Info

Publication number
EP4704833A2
EP4704833A2 EP24798171.5A EP24798171A EP4704833A2 EP 4704833 A2 EP4704833 A2 EP 4704833A2 EP 24798171 A EP24798171 A EP 24798171A EP 4704833 A2 EP4704833 A2 EP 4704833A2
Authority
EP
European Patent Office
Prior art keywords
compound
disorder
minutes
cycloalkyl
life
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24798171.5A
Other languages
English (en)
French (fr)
Inventor
Alan Gibbs
Tanweer Khan
Bob PERNI
Glenn Short
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atai Therapeutics Inc
Original Assignee
Atai Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atai Therapeutics Inc filed Critical Atai Therapeutics Inc
Publication of EP4704833A2 publication Critical patent/EP4704833A2/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP24798171.5A 2023-04-27 2024-04-29 Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen Pending EP4704833A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363576462P 2023-04-27 2023-04-27
PCT/US2024/026797 WO2024227149A2 (en) 2023-04-27 2024-04-29 Alkoxy and carbamoyl quaternary amine salts as prodrugs of trpytamines

Publications (1)

Publication Number Publication Date
EP4704833A2 true EP4704833A2 (de) 2026-03-11

Family

ID=93257462

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24798171.5A Pending EP4704833A2 (de) 2023-04-27 2024-04-29 Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen

Country Status (2)

Country Link
EP (1) EP4704833A2 (de)
WO (1) WO2024227149A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11759452B2 (en) 2020-05-08 2023-09-19 Psilera Inc. Compositions of matter and pharmaceutical compositions
JP2024521747A (ja) 2021-05-25 2024-06-04 アタイ セラピューティクス, インコーポレイテッド 新しいn,n-ジメチルトリプタミン塩および結晶塩形態

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL295371A (en) * 2020-02-04 2022-10-01 Mindset Pharma Inc Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders
US12017991B2 (en) * 2021-01-11 2024-06-25 Caamtech, Inc. Quaternary tryptamines and their therapeutic uses
WO2022261383A1 (en) * 2021-06-09 2022-12-15 ATAI Life Sciences AG Novel prodrugs and conjugates of dimethyltryptamine
EP4137131A1 (de) * 2021-08-17 2023-02-22 Centre National de la Recherche Scientifique (CNRS) Neuartige serotonin-analoga und deren verwendungen zur behandlung von eisenassoziierten erkrankungen
WO2024118767A2 (en) * 2022-11-29 2024-06-06 Caamtech, Inc. Tryptamine derivatives

Also Published As

Publication number Publication date
WO2024227149A3 (en) 2025-02-06
WO2024227149A2 (en) 2024-10-31

Similar Documents

Publication Publication Date Title
CN111818918B (zh) 用于治疗囊性纤维化的药物组合物
EP4704833A2 (de) Quaternäre alkoxy- und carbamoylaminsalze als prodrugs von trpytaminen
CA2744708C (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
TWI537269B (zh) 用於治療癌症及免疫及自體免疫疾病之細胞凋亡誘發劑
ES2666181T3 (es) Agentes inductores de la apoptosis para el tratamiento del cáncer y de enfermedades inmunitarias y autoinmunitarias
JP5852666B2 (ja) 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
WO2019191620A1 (en) Crystalline forms of modulators of cftr
WO2017114509A1 (zh) 醛基类化合物及其制法和用途
EP3508481A1 (de) Kristalline form von ozanimodhydrochlorid und herstellungsverfahren dafür
CN110088092A (zh) 化合物,获得化合物的方法,药物组合物,化合物的用途和治疗精神障碍和/或睡眠障碍的方法
AU2019265011B2 (en) Inhibitors of the RAS oncoprotein, methods of making and methods of use thereof
CN113549073B (zh) 作为JAK抑制剂的吡唑并[1,5-a]嘧啶衍生物
JP7628252B2 (ja) 二環式ピリジン組成物およびがんの治療にそれを使用する方法
TW201922690A (zh) 環-amp反應元素結合蛋白的抑制劑
CN105566302B (zh) 二氢吲哚酮化合物及其盐的结晶
CA3176727A1 (en) Antiviral 1,3-di-oxo-indene compounds
WO2021184958A1 (zh) 血管生成抑制剂、其制备方法和应用
CN120424027B (zh) 一种伏硫西汀半帕莫酸盐晶型
EP3781568A1 (de) Ponatinibform
TW202104216A (zh) Plk4抑制劑之結晶型
CN100569740C (zh) N-or酰胺类化合物,其制备方法和其应用
CN116120254B (zh) 13,14-双一氧化氮供体-β-榄香烯衍生物及其制备和应用
CN112759583B (zh) 包含呋喃基的喹啉类衍生物及其制备方法和用途
TW200307548A (en) Histamine-3 receptor ligands for diabetic conditions
CN103772374B (zh) 一种杂环类化合物及其应用

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251027

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR